Last Updated:
Name Designation Appointment Date Status
Irfan Ahmed Khan

Appointed as Director since May 2011

Director 16-May-2011 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Nikhil Ratilal Shah

Appointed as Director since May 2011

Director 16-May-2011 Current
Rajesh Raghunath Pawar

Appointed as Director since April 2013

Director 25-Apr-2013 Current

People Timeline

Explore the timeline of key personnel in Kratos Pharmaceuticals Limited's leadership journey.

Loading...
Contact Details
  • Address 317, Maker Chambers V 221, Nariman Point, Mumbai Maharashtra, 400021, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 400021
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Kratos Pharmaceuticals Limited?
You can contact Kratos Pharmaceuticals Limited through their registered address at 317, Maker Chambers V 221, Nariman Point, Mumbai Maharashtra, 400021, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Kratos Pharmaceuticals Limited?
The current directors of Kratos Pharmaceuticals Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • IRFAN AHMED KHAN
  • NIKHIL RATILAL SHAH
  • RAJESH RAGHUNATH PAWAR
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available